EarlyHealth Group

What EarlyHealth Group does

EarlyHealth Group is a private pharmaceutical services and life sciences solutions company headquartered in Al Satwa, United Arab Emirates, founded in 1984 and operating with 101-250 employees. The company's stated focus spans pharmaceutical medical services, clinical solutions research, and market access for the life sciences industry, serving healthcare and life sciences clients primarily across the Middle East.

The company's portfolio is built around two distinct pillars. The first is a capital-intensive pharmaceutical and life sciences cluster strategy, anchored by the US$200 million EarlyHealth City Barbados initiative — a partnership with government-backed Export Barbados that includes three manufacturing domes, a cybersecurity operations center, and a high-performance sports training facility in Newton, Christ Church, Barbados, with a stated goal of creating over 1,000 jobs. The second pillar is digital security, entered via a 50% equity acquisition of Dubai-based CYB3R Limited in October 2025, which provides AI-driven cybersecurity solutions to healthcare providers, government agencies, and other regulated industries. A June 2025 acquisition of Corena Ecza Deposu further extended pharmaceutical distribution reach into Turkey.

The business model is platform-based and B2B, combining physical life sciences infrastructure (manufacturing, research, and talent development) with digital security services. Revenue mechanics, pricing, and contract structures are not publicly disclosed. The company targets three primary vertical segments — healthcare providers, government agencies, and regulated industries — and maintains an explicit global footprint spanning the Middle East (UAE) and the Caribbean (Barbados), with no disclosed revenue, ARR, or investor-backed funding history.

Name

EarlyHealth Group

Legal name

EarlyHealth Group

Website

https://early-health.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

EarlyHealth Group is a UAE-based private pharmaceutical services and life sciences company, founded in 1984, that serves healthcare providers, government agencies, and regulated industries across the Middle East and Caribbean through pharmaceutical manufacturing, clinical research, and AI-driven cybersecurity via its CYB3R subsidiary.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services

NAICS

Health Care and Social Assistance (62)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Pharmaceutical services
• Clinical research solutions
• Market access services
• Life sciences manufacturing
• Healthcare cybersecurity

Headquarters

HQ city

Al Satwa

HQ country

United Arab Emirates

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Core offering

EarlyHealth Group is a global pharmaceutical services and life sciences solutions company providing clinical research, market access, and pharmaceutical services to healthcare, government, and regulated-industry clients. The company is expanding its portfolio to include AI-driven cybersecurity solutions through its 50% stake in Dubai-based CYB3R Limited, serving healthcare and government clients across the Middle East and Caribbean regions.

Product overview

EarlyHealth Group is a global pharmaceutical services and life sciences solutions company operating a platform-based model. The company offers pharmaceutical manufacturing and life sciences research through its flagship initiative EarlyHealth City Barbados ($200 million pharmaceutical and life sciences cluster in Newton, Christ Church, Barbados), while expanding into digital security through its 50% stake in CYB3R, a Dubai-based AI-driven cybersecurity firm serving healthcare, government, and regulated industries. The portfolio combines physical life sciences infrastructure with digital security services to position the company at the intersection of healthcare and digital transformation.

Differentiator

Problem solved

Functional benefit

Products and services

• CYB3R AI-driven Cybersecurity Solutions
• Pharmaceutical and Clinical Solutions Services

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered flagship and core.

• Export BarbadosflagshipStrategic or Co-development Partner · 17 November 2025Export Barbados and EarlyHealth Group signed a Letter of Intent to establish EarlyHealth City Barbados, a $200 million pharmaceutical and life sciences cluster. The project aims to position Barbados as a Caribbean life sciences hub, creating over 1,000 jobs and developing local talent in pharmaceutical manufacturing and research.
• CYB3R LimitedcoreStrategic or Co-development Partner · 12 October 2025EarlyHealth Group acquired a 50% equity stake in Dubai-based cybersecurity firm CYB3R. The partnership expands EarlyHealth's digital security portfolio to serve healthcare and government clients globally, integrating CYB3R's AI-driven cybersecurity solutions into EarlyHealth's international platform.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Syneos Health: Clinical and commercial solutions provider spanning CRO and market access services — overlaps directly with EarlyHealth's clinical research and market access focus.
• IQVIA: Global CRO and life sciences services platform combining clinical research, real-world evidence and market access — the closest scaled analog to EarlyHealth's stated pharma services and market access positioning.
• ICON plc: Major global contract research organization providing clinical and bioanalytical services to pharma and biotech — directly comparable to a pharma services / clinical solutions platform.
• Charles River Laboratories: Provides research models, preclinical and clinical support services to the biopharma industry — comparable to EarlyHealth's clinical and life sciences research offerings.
• Catalent: Global CDMO offering drug development, delivery and manufacturing solutions — directly comparable to EarlyHealth's planned manufacturing capacity at the Barbados cluster.
• Recipharm: European CDMO providing contract development and manufacturing services to pharma — directly comparable in business model and customer profile to EarlyHealth's pharma services offering.

Broad incumbents

• Lonza Group: Large, diversified CDMO with global manufacturing footprint — relevant incumbent analog for EarlyHealth's ambitions to scale contract pharma manufacturing through the Barbados cluster.
• WuXi AppTec: Global CRO/CDMO with a broad services portfolio spanning discovery, development and manufacturing — relevant incumbent comparable to EarlyHealth's platform model, particularly its Asia-linked pharma services.

Emerging players

• Samsung Biologics: Asia-based biologics CDMO rapidly scaling large-scale manufacturing capacity — comparable trajectory to EarlyHealth's planned build-out of manufacturing domes in Barbados.

Regional players

• Hikma Pharmaceuticals: MENA-headquartered generics and injectables manufacturer with broad regional distribution — a regional comparable for EarlyHealth's Gulf-rooted pharma services and distribution ambitions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/earlyhealth-group

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EarlyHealth Group